Very recently Anastasios Gkiokas shared our view on “Securing coverage for digital diagnostic solutions”. Read the blog entry for the key highlights of his talk.
NHSx Digital Technology Assessment Criteria (Beta)
Recently in Oct 2020, the NHSx, UK’s National Health Service arm in charge of digital and data, launched a digital technology assessment criteria (DTAC) beta that assesses more basic user aspects of digital solutions including clinical safety, data protection, technical assurance, interoperability, usability, and accessibility.
In conversation with FibriCheck CEO Lars Grieten: Challenges of a high-impact digital atrial fibrillation solution
Digital atrial fibrillation (AF) screening and monitoring solution FibriCheck is facilitating better outcomes for AF patients, who suffer from this elusive condition that entails irregular heartbeat. The solution, developed by Qompium, allows patients to measure their heart rhythm via their smartphones or wearables. We had a chat with CEO Lars Grieten on the journey towards 350,000 users, the impact of Covid and what’s in the pipeline. This is a bonus piece in addition to our 2 part series (see part 1, part 2) for AF awareness month.
Germany’s Digital Healthcare Act – A glimpse on the first applicants
Digital Healthcare Act (DiGAV) aims to create a solid reimbursement pathway for digital health solutions in the German healthcare market. BfArM, the body that determines which solution will be enlisted in the DiGA registry, opened its application portal in May, and it is expected to publish the first application results later this month.
Meanwhile, the umbrella association for digital healthcare acts (Spitzenverband Digitale Gesundheitsversorgung) has disclosed some of the first companies that applied for inclusion in the DiGA registry.
Spotlight on Germany’s Digital Healthcare Reimbursement Pathway
Germany’s digital healthcare market is about to open up, thanks to the Digital Healthcare Act (DiGAV), which puts in place a solid reimbursement pathway for digital health solutions. In this blog post, we answer some frequently asked questions, relevant to market access, with insights from recently published documents/conferences on the topic.
3+1 highlights from Startup Creasphere Batch #3
Switzerland Health 2030 – The new health policy strategy focuses on digital transformation
Improving Access for Digital Health in Germany
12 exciting digital health start-ups - Startup Creasphere Batch #3
Payer Trends in Diagnostics & Digital Health – What’s new?
Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:
Growing appetite for diagnostics health technology assessment in Europe
Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US
Payers start to embrace Digital Health
(Video) Introducing CENTIVIS - Diagnostics Value Captured
Risk-based Digital Health Classification by NICE
5 tips for successful corporate/startup digital health collaborations
Startup Creasphere, the Digital Health story continues...
Startup Creasphere, the Digital Health story continues...
After a successful pilot phase, CENTIVIS is happy to further support Startup Creasphere, a Digital Health innovation platform backed by Roche Diagnostics and Plug and Play. Collaborating with industry leading life science company, accelerator network and disruptive startups is a unique constellation to pilot innovative solutions.
Digital Health Demo Day - June 7, Munich
Digital Health Demo Day - June 7, Munich
It has been an exciting quarter working together with various startups, Roche, WERK1 and Plug and Play on digital health co-creation projects.
The finish line is approaching, „Batch Zero“ startups are ready to showcase all they have achieved so far!
Check out the event link
CENTIVIS awarded ‘Approved Facilitator’ status for NICE META Tool
CENTIVIS awarded ‘Approved Facilitator’ status for latest NICE META Tool
CENTIVIS has recently been approved by NICE (National Institute for Health and Care Excellence) as one of the limited number of qualified Medtech Early Technical Assessment (META) Tool facilitators.
NICE has developed the META tool to help medical technology developers understand what evidence is needed to make a convincing case to payers and commissioners.
"With NICE META tool our diagnostics and digital health clients will benefit from a structured, streamlined and affordable evidence review to better capture the value of their diagnostic and digital health solutions"
Do you want to know more? SCHEDULE A CALL or visit the product page
Norbert
